Literature DB >> 9394061

Leptospirosis in the Republic of Ireland: 1985 to 1996.

M C Hogan1, G Pate, S J McConkey, D O'Flanagan, C Mongan, G J Mellotte.   

Abstract

Official government statistics and serological laboratory data provide limited information about the incidence of leptospirosis in the Republic of Ireland. The mean annual notified incidence in the Republic of Ireland from 1985 to 1996 was 1.3/million. The incidence according to hospital discharge diagnosis was higher at 4.9/million. One hundred and seventy-five serologically confirmed cases of leptospirosis were reported from 1986 to 1996, giving a mean annual incidence of 4.5/million. The true incidence of leptospirosis in the Republic of Ireland is probably higher, as hospital discharge data are incomplete and full serological testing was not always performed. Our data indicate that leptospirosis is an underestimated public health problem with only 26% of cases being notified. A national communicable disease surveillance centre in the Republic of Ireland would facilitate better monitoring and understanding of this disease.

Entities:  

Mesh:

Year:  1997        PMID: 9394061

Source DB:  PubMed          Journal:  Commun Dis Rep CDR Rev        ISSN: 1350-9349


  3 in total

1.  National Scientific Medical Meeting. 26-27 March 1999. Abstracts.

Authors: 
Journal:  Ir J Med Sci       Date:  1999 Apr-Jun       Impact factor: 2.089

2.  Emerging Infectious Disease Implications of Invasive Mammalian Species: The Greater White-Toothed Shrew (Crocidura russula) Is Associated With a Novel Serovar of Pathogenic Leptospira in Ireland.

Authors:  Jarlath E Nally; Zbigniew Arent; Darrell O Bayles; Richard L Hornsby; Colm Gilmore; Siobhan Regan; Allan D McDevitt; Jon Yearsley; Séamus Fanning; Barry J McMahon
Journal:  PLoS Negl Trop Dis       Date:  2016-12-09

3.  Leptospirosis in Ireland: annual incidence and exposures associated with infection.

Authors:  P Garvey; J Connell; D O'Flanagan; P McKeown
Journal:  Epidemiol Infect       Date:  2013-08-05       Impact factor: 4.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.